InvestorsHub Logo
Followers 7
Posts 649
Boards Moderated 0
Alias Born 08/18/2017

Re: None

Wednesday, 06/09/2021 5:25:04 PM

Wednesday, June 09, 2021 5:25:04 PM

Post# of 4231
Vuzix just increased their dominance in the medical industry.

Vuzix Smart Glasses Expand AR Surgical Product Presence to Support Shoulder, Knee and Spine Surgeries

- NextAR surgical AR platform developed by Medacta International receives CE marking for knee, shoulder and spine applications.
- NextAR surgical AR platform receives US Food and Drug Administration (FDA) clearance for shoulder application.

ROCHESTER, N.Y., June 9, 2021 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced the market expansion to support the NextAR surgical AR platform developed by Medacta International, one of the world's largest providers of innovative orthopedic products focusing on healthcare sustainability. Having used the Vuzix Blade to complete the first smart glasses-based total knee replacement in the US in 2020, Medacta recently received its CE marking for knee, shoulder and spine applications for its NextAR Augmented Reality Surgical Platform in Europe and US Food and Drug Administration (FDA) clearance for shoulder application. CE marking is an administrative marking with which the manufacturer or importer affirms its conformity with European health, safety, and environmental protection standards for products sold within the European marketplace.

The NextAR platform employs a preoperative scan, with proprietary algorithms that create a personalized biomechanical model for each replacement. Surgeons equipped with Vuzix Blade Smart Glasses can then access biomechanical visualizations using augmented reality in real time, without having to divert their eyes from the procedure to glance at a computer screen. NextAR's smart delivery tools may improve efficiency in computer-assisted surgery by offering a compact solution that avoids the need for a bulky external detection platform. With a low upfront capital investment and overall lower cost per case compared to other technologies, this translates into greater efficiency in the operating room, which is particularly relevant for US Ambulatory Surgery Centers (ASCs).

"We're proud to provide the hardware backbone for Medacta's NextAR platform as it continues to branch into new surgical applications which now include knee, shoulder and spine in Europe and knee and shoulder in the United States," said Paul Travers, President and Chief Executive Officer at Vuzix. "The Vuzix Smart Glasses are lightweight, comfortable and completely wireless, which means surgeons have complete freedom of movement and can wear them for extended operations."

https://ir.vuzix.com/news-events/press-releases/detail/1895/vuzix-smart-glasses-expand-ar-surgical-product-presence-to
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VUZI News